2017

Adalimumab +/- azathioprine tight control vs clincal management in CD

Low-Dose Cannabidiol Is Safe but Not Effective in the Treatment for Crohn’s Disease, a Randomized Controlled Trial

Adalimumab in stricturing CD

EEN in complicated CD

Adalimumab in CD

Infliximab in CD safety

Filgotinib in CD

Golimumab in pediatric UC

ADA vs AZA in postop recurrence in CD

Efficacy and Safety of Oral Budesonide in Patients with Active Crohn’s Disease in Japan: A Multicenter, Double-Blind, Randomized, Parallel-Group Phase 3 Study